Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain

This publication has 12 references indexed in Scilit:

• (−)Deprenyl and (−)1-phenyl-2-propylaminopentane, [(−) PPAP] act primarily as potent stimulants of action potential — transmitter release coupling in the catecholaminergic neurons
  Life Sciences, 1996
• High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers
  Life Sciences, 1996
• Rationale for (−)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes
  Biomedicine & Pharmacotherapy, 1995
• Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medication
  Life Sciences, 1995
• Memories of my 45 Years in Research
  Basic & Clinical Pharmacology & Toxicology, 1994
• Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseases
  Medicinal Research Reviews, 1992
• The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl
  Mechanisms of Ageing and Development, 1988
• Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
• MONOAMINE-OXIDASE INHIBITORS
  The Lancet, 1965
• Amphetamine-Like Activity of β-Phenethylamine After A Monoamine Oxidase Inhibitor in vivo
  Journal of Pharmacy and Pharmacology, 1963